We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$223M
AUM Growth
-$41.4M
Cap. Flow
-$38.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$2.06M
2
PBR icon
Petrobras
PBR
+$2M
3
VALE icon
Vale
VALE
+$1.96M
4
CQP icon
Cheniere Energy
CQP
+$1.94M
5
STR
Sitio Royalties
STR
+$1.94M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$2.62M
2
EXR icon
Extra Space Storage
EXR
+$2.49M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.46M
4
IMO icon
Imperial Oil
IMO
+$2.45M
5
AVNT icon
Avient
AVNT
+$2.42M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Real Estate 20.02%
3 Healthcare 16.51%
4 Energy 10.55%
5 Utilities 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCIC
176
BCP Investment Corp
BCIC
$88.3M
$314K 0.14%
12,985
+1,080
+9% +$26.4K
KNSA icon
177
Kiniksa Pharmaceuticals
KNSA
$6.11B
$298K 0.13%
30,021
– –
LGND icon
178
Ligand Pharmaceuticals
LGND
$5.94B
$292K 0.13%
4,165
– –
ADCT icon
179
ADC Therapeutics
ADCT
$141M
$282K 0.13%
19,193
– –
YMAB
180
DELISTED
Y-mAbs Therapeutics
YMAB
$281K 0.13%
23,646
– –
CCXI
181
DELISTED
ChemoCentryx, Inc.
CCXI
$281K 0.13%
11,214
– –
VNDA icon
182
Vanda Pharmaceuticals
VNDA
$310M
$264K 0.12%
23,335
– –
ZLAB icon
183
Zai Lab
ZLAB
$2.1B
$261K 0.12%
5,933
– –
AUPH icon
184
Aurinia Pharmaceuticals
AUPH
$1.92B
$256K 0.11%
20,653
– –
ONC
185
BeOne Medicines Ltd
ONC
$34.3B
$252K 0.11%
1,336
– –
MIRM icon
186
Mirum Pharmaceuticals
MIRM
$6.84B
$246K 0.11%
11,161
-656
-6% -$13.4K
BPMC
187
DELISTED
Blueprint Medicines
BPMC
$240K 0.11%
3,762
– –
MRNA icon
188
Moderna
MRNA
$22.1B
$231K 0.1%
1,342
– –
RLMD icon
189
Relmada Therapeutics
RLMD
$549M
$230K 0.1%
8,516
-499
-6% -$10.3K
BNTX icon
190
BioNTech
BNTX
$23.4B
$229K 0.1%
1,344
– –
FULC icon
191
Fulcrum Therapeutics
FULC
$248M
$225K 0.1%
9,496
-563
-6% -$7.97K
TSVT
192
DELISTED
2seventy bio
TSVT
$224K 0.1%
13,134
– –
ACET icon
193
Adicet Bio
ACET
$76.7M
$217K 0.1%
679
-40
-6% -$9.2K
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$12.4B
$210K 0.09%
2,139
-131
-6% -$11K
AXSM icon
195
Axsome Therapeutics
AXSM
$12.1B
$209K 0.09%
5,053
-297
-6% -$9.21K
KZR
196
DELISTED
Kezar Life Sciences
KZR
$208K 0.09%
1,254
-75
-6% -$10.8K
KURA icon
197
Kura Oncology
KURA
$826M
$203K 0.09%
12,601
-753
-6% -$10.9K
ARQT icon
198
Arcutis Biotherapeutics
ARQT
$3.55B
$200K 0.09%
10,359
-606
-6% -$10.3K
BLUE
199
DELISTED
bluebird bio
BLUE
$197K 0.09%
2,030
– –
PRVB
200
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$194K 0.09%
26,467
-1,563
-6% -$9.35K
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Virtus ETF Advisers held 420 positions worth $223M, down 16% from $265M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers withdrew a net $38.1M in Q1 2022, closing 47 positions and reducing 231 holdings. Its most notable exit was Boise Cascade, an estimated $2.62M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in The Mosaic Company worth $2.75M.

  • Virtus ETF Advisers's largest Q1 2022 buy was The Mosaic Company: 41,283 shares worth $2.75M.
  • Virtus ETF Advisers added most to Agnico Eagle Mines in Q1 2022, an estimated $1.28M increase.
  • Virtus ETF Advisers's biggest Q1 2022 reduction was Gold Fields, cutting an estimated $1.09M.
  • Virtus ETF Advisers fully exited Boise Cascade in Q1 2022, selling an estimated $2.62M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $223M portfolio in Q1 2022.
  • Virtus ETF Advisers opened 44 new positions and closed 47 in Q1 2022.
  • Virtus ETF Advisers's portfolio value fell 16% quarter-over-quarter to $223M.

Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.